IRIX Stock Analysis: Buy, Sell, or Hold?
IRIX - Iridex Corp
$0.98
0.03 (3.23%)
▲
5d:
-27.39%
30d:
-30.48%
90d:
-14.01%
WAIT
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When IRIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: IRIX is down 27.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: IRIX is down 27.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: IRIX is currently trading at $0.98, which is considered oversold relative to its 30-day fair value range of $1.15 to $1.45.
Technical Outlook: Technically, IRIX is in a strong uptrend. Immediate support is located at $0.95, while resistance sits at $1.42. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+104.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IRIX is in a strong uptrend. Immediate support is located at $0.95, while resistance sits at $1.42. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+104.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.15 -
$1.45
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 104.0% below Wall St target ($2.00)
- WARNING: Recommendation downgraded due to -27.4% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.15 -
$1.45
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.42
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
769.23
Wall Street Target
$2.00
(+104.0%)
Revenue Growth (YoY)
7.8%
Profit Margin
-10.0%
Share & Embed Analysis
Last updated: April 02, 2026 7:21 PM ET
Data refreshes hourly during market hours. Next update: 8:21 PM
Data refreshes hourly during market hours. Next update: 8:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRIX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
William M Moore
BUY
21843 shares
2025-11-17
William M Moore
BUY
28157 shares
2025-11-14
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
